Technology
Health
Medical

Soleno Therapeutics

$2.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.30 (14.63%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SLNO and other stocks, options, ETFs, and crypto commission-free!

About

Soleno Therapeutics, Inc. Common Stock, also called Soleno Therapeutics, is a healthcare company, focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Read More It markets CoSense End-Tidal Carbon Monoxide monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Employees
23
Headquarters
Redwood City, California
Founded
1999
Market Cap
65.10M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
443.90K
High Today
$2.55
Low Today
$2.11
Open Price
$2.19
Volume
1.03M
52 Week High
$5.07
52 Week Low
$1.11

Collections

Technology
Health
Medical
Therapy
Healthcare
2014 IPO
US
North America

News

Simply Wall St17h

Did Changing Sentiment Drive Soleno Therapeutics’s (NASDAQ:SLNO) Share Price Down A Worrying 68%?

Soleno Therapeutics, Inc. (NASDAQ:SLNO) shareholders are doubtless heartened to see the share price bounce 52% in just one week. But that doesn’t change the fact that the returns over the last three years have been disappointing. In that time, the share price dropped 68%. So it’s good to see it climbing back up. The rise has some hopeful, but turnarounds are often precarious. View our latest analysis for Soleno Therapeutics Soleno Therapeutics didn’t have any revenue in the last year, so it’s fair to say ...

212
InvestorPlaceMar 15

Soleno Therapeutics News: Why SLNO Stock Is Skyrocketing Today Soleno Therapeutics News: Why SLNO Stock Is Skyrocketing Today

Soleno Therapeutics (NASDAQ: SLNO ) had a Friday to remember as the biopharmaceutical company made some headway in a successful clinical trial of a treatment for a genetic disorder.

192
BenzingaMar 15

Soleno Therapeutics' 200% Spike: What You Need To Know (NASDAQ:SLNO)

Shares of thinly traded micro-cap biotech Soleno Therapeutics Inc (NASDAQ: SLNO) were surging Friday on over 700 times their average volume.

1,005

Earnings

-$0.36
-$0.23
-$0.11
$0.02
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
$0.02 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.